Intervention Review

Chemotherapy for malignant germ cell ovarian cancer in adult patients with early stage, advanced and recurrent disease

  1. Albiruni Ryan Abdul Razak1,*,
  2. Louise Li2,
  3. Andrew Bryant3,
  4. Ivan Diaz-Padilla1

Editorial Group: Cochrane Gynaecological Cancer Group

Published Online: 16 MAR 2011

Assessed as up-to-date: 9 FEB 2011

DOI: 10.1002/14651858.CD007584.pub2


How to Cite

Abdul Razak AR, Li L, Bryant A, Diaz-Padilla I. Chemotherapy for malignant germ cell ovarian cancer in adult patients with early stage, advanced and recurrent disease. Cochrane Database of Systematic Reviews 2011, Issue 3. Art. No.: CD007584. DOI: 10.1002/14651858.CD007584.pub2.

Author Information

  1. 1

    Princess Margaret Hospital, Department of Medical Oncology, Toronto, ON, Canada

  2. 2

    Northern Centre for Cancer Treatment, Medical Oncology Department, Newcastle upon Tyne, UK

  3. 3

    Newcastle University, Institute of Health and Society, Newcastle upon Tyne, UK

*Albiruni Ryan Abdul Razak, Department of Medical Oncology, Princess Margaret Hospital, 610 University Avenue, Toronto, ON, M5G 2M9, Canada. albiruni_ryan@yahoo.co.uk.

Publication History

  1. Publication Status: New
  2. Published Online: 16 MAR 2011

SEARCH

  1. Current Version

    Chemotherapy for malignant germ cell ovarian cancer in adult patients with early stage, advanced and recurrent disease

    Albiruni Ryan Abdul Razak, Louise Li, Andrew Bryant and Ivan Diaz-Padilla

    Article first published online: 16 MAR 2011 | DOI: 10.1002/14651858.CD007584.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Chemotherapy for malignant germ cell ovarian cancer in patients with early stage, advanced and recurrent disease

    Albiruni Ryan Abdul Razak, Louise Li, Andrew Hughes, Graham Dark, Andrew Bryant and Heather O Dickinson

    Article first published online: 21 JAN 2009 | DOI: 10.1002/14651858.CD007584